— The Child Health Research Institute — Research Resources — Clinical Studies — COVID-19 Pediatric Oral Treatment Study

COVID-19 Pediatric Oral Treatment Study

group of kids lined up looking at camera

Hope For Children – Moving Beyond COVID-19

A clinical study is underway for the potential treatment of COVID-19 in recently diagnosed or symptomatic children/teens at risk for severe illness.

This study may be an option for children and teens who are:

6 to 17 years of age
Having at least one sign/symptom of COVID-19
Able to swallow tablets
Able to meet minimum weight requirements
Having at least one of the following characteristics of underlying medical conditions

✓ Overweight or obese
✓ Current smoker
✓ Immunosuppressive disease (i.e. cancer treatment, HIV, autoimmune disorders)
✓ Chronic lung, heart, or kidney disease
✓ Hypertension (high blood pressure)
✓ Type 1 or Type 2 diabetes
✓ Sickle cell disease
✓ Neurodevelopmental disorder (i.e. cerebral palsy, Downs syndrome)

Note: There are other requirements to participate in this study. A study team member will help determine if this study is right for your family.

Joining a clinical trial is an important and personal decision.

Interested?

For additional information, please fill out this survey. Or call, text or email for Information:
PCPREP@unmc.edu | 402-670-0360

Principal Investigator:
Brad Brabec, MD
Child Health Research Institute, UNMC/Children's Hospital & Medical Center

985456 Nebraska Medical Center
Omaha, NE 68198-5456

IRB# 174-22-CB